Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00324207 · ClinicalTrials.gov registry record
Molecular Quantification of Insulin mRNA
A clinical trial, sponsored by Children's Mercy Hospital Kansas City.
- Completed
- Registry status
- 400
- Enrollment target
NCT00324207: Completed study, sponsored by Children's Mercy Hospital Kansas City.
NCT00324207 is a clinical trial that has completed, run by Children's Mercy Hospital Kansas City. The registered enrollment target is 400 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00324207 has completed, sponsored by Children's Mercy Hospital Kansas City.
- COMPLETED
- Registry status
- 400 participants
- Enrollment target
Study Summary
The objectives of this study are to: 1. quantitate the level of insulin mRNA in the while cell fraction of whole blood in selected groups of subjects, 2. determine the gene expression of markers of white cell activation in the white cell fraction of whole blood in selected subjects, 3. determine the identity of the white cell responsible for expression of insulin mRNA and 4. determine protein expression of mRNA of insulin/proinsulin and selected genes of white cell activation.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2006-02 |
| Est. Completion | 2009-01 |
What the finished NCT00324207 record still lists
NCT00324207 is an observational study that tracks outcomes without assigning an intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00324207 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00324207 about?
NCT00324207 is a clinical study titled "Molecular Quantification of Insulin mRNA". The objectives of this study are to: 1. quantitate the level of insulin mRNA in the while cell fraction of whole blood in selected groups of subjects, 2. determine the gene expression of markers of white cell activation in the white cell fraction of whole blood in selected subjects, 3. determine th...
What is the current status of trial NCT00324207?
This trial is currently completed. The enrollment target is 400 participants. The study started on 2006-02. Estimated completion is 2009-01.
Who is sponsoring clinical trial NCT00324207?
This trial is sponsored by Children's Mercy Hospital Kansas City, which has 184 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01665326 · 400 participants
Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease
- NCT02108054 · 400 participants · NA
Behavioral and Functional Task Development, Implementation, and Testing
- NCT02216500 · 400 participants · NA
Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy
- NCT02250352 · 400 participants
Core Biopsies for Establishing a Breast Tumor Tissue Repository
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia